Paper Details

  1. Home
  2. Paper Details

Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine.

Author: BeckIngrid A, BlancoAna Judith, CarlssonJacquelyn, DrossSandra, FrenkelLisa M, GanttSoren, GloydStephen, JamisseLilia, MatedianaEduardo, MatunhaLaurinda, MicekMark A, MontoyaPablo, SeidelKristy

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

This study evaluated the effectiveness of a short course of zidovudine (ZDV) in reducing the risk of nevirapine (NVP)-resistance in HIV-1 infected pregnant women receiving a single-dose of NVP for prevention of mother-to-child transmission. The results showed that women who received ZDV+sdNVP had a lower risk of NVP-resistance compared to those who received only sdNVP (35.5% vs. 72.7%).
Paper Details　
Original Abstract of the Article :
Single-dose nevirapine (sdNVP) given to prevent mother-to-child-transmission of HIV-1 selects NVP-resistance. Short-course zidovudine (ZDV) was hypothesized to lower rates of NVP-resistance. HIV-1 infected pregnant women administered sdNVP with or without short-course ZDV were assessed for HIV-1 mut...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415891/

データ提供：米国国立医学図書館（NLM）

Preventing HIV Transmission: The Role of Zidovudine

This study explores the impact of short-course zidovudine (ZDV) on the development of nevirapine (NVP)-resistance in HIV-infected pregnant women. The researchers investigated whether ZDV, a common antiretroviral drug, could help prevent the emergence of NVP-resistance, a potential complication in preventing mother-to-child transmission (MTCT) of HIV.

Zidovudine: A Protective Shield Against Resistance

The study found that short-course ZDV was associated with a lower rate of NVP-resistance mutations in pregnant women receiving single-dose NVP for MTCT prevention. This finding is like discovering a protective oasis in the desert, shielding against the threat of drug resistance and enhancing the effectiveness of treatment.

A More Effective Approach to HIV Prevention

This research suggests that integrating short-course ZDV into MTCT prevention strategies could be a valuable tool for reducing NVP-resistance and improving the effectiveness of HIV prevention efforts. This could lead to a safer and more sustainable future for both mothers and their children, much like a clear path through a desert, leading to a brighter destination.

Dr.Camel's Conclusion

This study highlights the potential benefits of incorporating short-course ZDV into MTCT prevention strategies. By reducing the risk of NVP-resistance, this approach could significantly improve the effectiveness of HIV prevention efforts, offering a ray of hope in the desert of this global health challenge.

Date :
  1. Date Completed 2012-07-25
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

22492850

DOI: Digital Object Identifier

PMC3415891

Related Literature

Article Analysis
・Effects of nevirapine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.